diarrhea from glp 1 on GLP-1? Here's What's Actually Happening Effects of GLP-1 receptor agonist

B12 adequacy is directly relevant here since B12 deficiency independently causes cognitive symptoms and mood disturbance, which is another reason the B12-containing formulation is preferred for long-term use

where Xaa represents any amino acid) and also acts on substrates that bear other residues, such as glycine, serine, valine and leucine (Reference Lambeir, Durinx and Scharp93)

Clinical Take-Home Messages GLP-1RAs are no longer diabetes-only drugs. They are becoming: Obesity therapies Cardiovascular protective agents Anti-inflammatory therapies Neuroprotective candidates Metabolic disease modifiers Conclusion We are witnessing a historic transition in medicine

Most patients stabilise after dose titration

Please note that such risks have not been conclusively established in humans and appear consistent with other GLP-1 receptor agonists

The American Heart Association (AHA) guidelines suggest the initiation of SGLT-2i or GLP-1RA in patients with T2DM who have additional cardiovascular risk factors [14]